3-Methylmethcathinone - Clearmind Medicine
Alternative Names: 3-MMC - Clearmind MedicineLatest Information Update: 21 Aug 2023
At a glance
- Originator Clearmind Medicine
- Class Amphetamines; Ketones; Methylamines; Neuropsychotherapeutics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Dyskinesias
Most Recent Events
- 17 Aug 2023 Chemical structure information added
- 08 Aug 2023 Clearmind Medicine files for provisional patent application with the United States Patent and Trademark Office (USPTO) for psychedelic molecule 3-methylmethcathinone
- 01 Aug 2023 Preclinical trials in Dyskinesias in Canada (unspecified route)